34 results on '"Acerno S"'
Search Results
2. Intrathecal rituximab for IgG4-related hypertrophic pachymeningitis
- Author
-
Della-Torre, E, Campochiaro, C, Cassione, EB, Albano, L, Gerevini, S, Bianchi-Marzoli, S, Bozzolo, E, Passerini, G, Lanzillotta, M, Terreni, M, Callea, M, Trimarchi, M, Mortini, P, Tresoldi, M, Acerno, S, Dagna, L, DELLA TORRE , EMANUEL, Della-Torre, E, Campochiaro, C, Cassione, Eb, Albano, L, Gerevini, S, Bianchi-Marzoli, S, Bozzolo, E, Passerini, G, Lanzillotta, M, Terreni, M, Callea, M, Trimarchi, M, Mortini, P, Tresoldi, M, Acerno, S, Dagna, L, and DELLA TORRE, Emanuel
- Subjects
Pathology ,medicine.medical_specialty ,IgG4 - IgG4-related disease – Pachymeningitis – Rituximab - Intrathecal ,business.industry ,Central nervous system ,medicine.disease ,03 medical and health sciences ,Psychiatry and Mental health ,0302 clinical medicine ,Cerebrospinal fluid ,Atrophy ,medicine.anatomical_structure ,Monoclonal ,Systemic administration ,medicine ,Nasal septum ,Optic nerve ,Surgery ,Rituximab ,030212 general & internal medicine ,Neurology (clinical) ,business ,030217 neurology & neurosurgery ,medicine.drug - Abstract
Intrathecal administration of rituximab—an anti-CD20 monoclonal antibody—is emerging as a promising therapeutic strategy for B cell lymphomas of the central nervous system (CNS).1 2 The rationale for administering rituximab directly into the cerebrospinal fluid (CSF) stems from the need to achieve optimal therapeutic concentrations within the intrathecal compartment. Rituximab, in fact, has a high molecular weight and only 0.1%–0.5% of its plasmatic concentrations crosses the ‘blood-brain barrier’ (BBB) after intravenous infusion.1 In addition, despite inducing prolonged depletion of circulating B lymphocytes, systemic rituximab does not affect malignant B cells in CNS lymphomas.2 Hypertrophic pachymeningitis (HP) is the most frequently encountered CNS manifestation of IgG4-related disease (IgG4-RD), a fibroinflammatory condition of unclear aetiology.3 The intrathecal synthesis of IgG4 in patients with IgG4-related hypertrophic pachymeningitis(RHP) and the clinical improvement after rituximab in patients with systemic involvement, support a pathogenic role of B lymphocytes.4–6 Among IgG4-RD manifestations, however, IgG4-RHP stands out for a certain resistance to intravenous rituximab raising the possibility that systemic administration might not be as effective on putative pathogenic B cells residing in inflammatory niches within the CNS.4 Here, we report the first case of IgG4-RHP treated with intrathecal rituximab. A young adult patient was admitted in April 2015 for rapidly progressive frontal headache and complete visual loss on the right eye. Imaging studies of the head and neck revealed diffuse pachymeningitis with bone erosions, thickening of the nasal septum, hard palate tumefaction, and bilateral optic neuritis; neuro-ophthalmological examination reported asymmetrical signs of optic nerve fibre atrophy (right >left) with loss of colour vision and complete depression of the visual field on the right eye (figure 1 and see online supplementary figure e1). Laboratory and CSF analyses at the time of admission are reported in online …
- Published
- 2017
- Full Text
- View/download PDF
3. VP21.06: Functional neurodevelopment evidence in a case of Chiari II with prenatal surgery of open spina bifida
- Author
-
Cavoretto, P.I., primary, Canini, M., additional, Candiani, M., additional, Caglioni, M., additional, Falini, A., additional, Baldoli, C., additional, Mortini, P., additional, Acerno, S., additional, Peralta, F., additional, and Rosa, P.A. Della, additional
- Published
- 2020
- Full Text
- View/download PDF
4. Indium-111 pentetreotide single-photon emission tomography in patients with TSH-secreting pituitary adenomas: Correlation with the effect of a single administration of octreotide on serum TSH levels
- Author
-
Losa, M., Magnani, P., Mortini, P., Persani, L., Acerno, S., Giugni, E., Songini, C., Fazio, F., Beck-Peccoz, P., and Giovanelli, M.
- Published
- 1997
- Full Text
- View/download PDF
5. Surgical Results in Microadenomas
- Author
-
Giovanelli, M., Losa, M., Mortini, P., Acerno, S., Giugni, E., Fahlbusch, Rudolf, editor, Bock, Wolfgang J., editor, Brock, Mario, editor, Buchfelder, Michael, editor, and Klinger, Margareta, editor
- Published
- 1996
- Full Text
- View/download PDF
6. Correlation between clinical characteristics and proliferative activity in patients with craniopharyngioma
- Author
-
Losa, M, Vimercati, A, Acerno, S, Barzaghi, R L, Mortini, P, Mangili, F, Terreni, M R, Santambrogio, G, and Giovanelli, M
- Published
- 2004
7. Neuroradiologic and neurophysiologic study of the cranio-cervical junction in children affected by achondroplasia
- Author
-
Kalapurackal M. A, Donghi V, Acerno S, Baldoli C, Medaglini S, WEBER , GIOVANNA, Kalapurackal M., A, Donghi, V, Acerno, S, Baldoli, C, Medaglini, S, and Weber, Giovanna
- Published
- 2013
8. Neurosurgical treatment of craniopharyngioma in adults and children: early and long-term results in a large case series
- Author
-
MORTINI , PIETRO, WEBER , GIOVANNA, Losa M, Pozzobon G, Barzaghi R, Riva M, Acerno S, Angius D, Chiumello G, Giovanelli M., Mortini, Pietro, Losa, M, Pozzobon, G, Barzaghi, R, Riva, M, Acerno, S, Angius, D, Weber, Giovanna, Chiumello, G, and Giovanelli, M.
- Abstract
"Object. Craniopharyngioma accounts for 2%-5% of all primary intracranial neoplasms. The optimal management of craniopharyngioma remains controversial. The authors evaluated the early results of surgery and the long-term risk of tumor recurrence in a large series of patients undergoing resection of craniopharyngiomas. Methods. Between 1990 and 2008, 112 consecutive patients (57 male and 55 female patients with a mean [+\/- SEM] age of 33.3 +\/- 1.8 years) underwent resection of craniopharyngiomas at the authors hospital. Recurrence or growth of residual tumor tissue during follow-up was assessed using MR imaging. Results. There were 3 perioperative deaths (2.7%). Severe adverse events were more frequent in patients who underwent operations via the transcranial route (37%) than the transsphenoidal approach (5.6%; p < 0.001). Magnetic resonance imaging showed radical resection of the tumor in 78 (71.6%) of the remaining 109 patients. Previous surgery and maximum tumor diameter were associated with persistence of disease after surgery. Craniopharyngioma recurred in 26(24.5%) of 106 patients. Presence of residual tumor on the first postoperative MR imaging, male sex, and no postoperative radiation therapy were associated with a risk of tumor recurrence. Quality-of-life data were assessed in the 91 patients who attended the authors' institution for follow-up visits. Among them, 8.8% patients were partially or completely dependent on others for daily living activities before surgery. This percentage increased to 14.3% at the last follow-up visit. The 5- and 10-year overall survival rates were 94.4% (95% CI 90.0%-98.8%) and 90.3% (95% CI 83.4%-97.3%), respectively. Conclusions. Complete surgical removal of craniopharyngioma can be achieved with reasonable safety in more than 70% of patients. Recurrence of craniopharyngioma may occur even after apparent radical excision. Prompt management of residual or recurring disease by radiotherapy, repeat surgery, or a combination of both is usually successful in controlling further tumor growth. (DOI: 10.3171\/2010.11.JNS10670)"
- Published
- 2011
9. Outcome prediction in severe closed head injury, magnetic resonance versus evoked potentials
- Author
-
Cenzato, M, Ducati, A, Anzalone, N, Beretta, L, Dell'Acqua, A, Citerio, G, Sacchi, L, Acerno, S, Dell'acqua, A, Acerno, S., CITERIO, GIUSEPPE, Cenzato, M, Ducati, A, Anzalone, N, Beretta, L, Dell'Acqua, A, Citerio, G, Sacchi, L, Acerno, S, Dell'acqua, A, Acerno, S., and CITERIO, GIUSEPPE
- Published
- 1994
10. Indium-111 pentetreotide single-photon emission tomography in patients with TSH-secreting pituitary adenomas: correlation with the effect of a single administration of octreotide on serum TSH levels RID B-6543-2008
- Author
-
Losa M, Magnani P, Persani L, Acerno S, Giugni E, Songini C, Fazio F, BeckPeccoz P, Giovanelli M., MORTINI , PIETRO, Losa, M, Magnani, P, Mortini, Pietro, Persani, L, Acerno, S, Giugni, E, Songini, C, Fazio, F, Beckpeccoz, P, and Giovanelli, M.
- Abstract
Few data are available on the visualization of somatostatin receptors in vivo in patients with thyrotropin (TSH)-secreting adenoma. We studied five patients with TSH-secreting adenomas using single-photon emission tomography (SPET) after administration of indium-111 pentetreotide. The intensity of In-111-pentetreotide uptake by the rumours was correlated with the degree of TSH suppression after a single administration of 100 mu g octreotide s.c. Five patients (three women and two men) aged 27-46 years were investigated. Except for one patient with acromegaly, all had pure TSH-secreting tumours. One patient was previously untreated, while two had received octreotide, one antithyroid drugs, and one radioiodine. In all patients SPET demonstrated increased uptake of In-111-pentetreotide by the pituitary adenoma. The target to non-target ratio (T/nT) of In-111-pentetreotide uptake was higher than 10 in three patients. Administration of 100 mu g octreotide s.c. caused a significant reduction in TSH levels from 4.8+/-1.4 mU/l to a nadir of 3.1+/-1.1 mU/l after 6 h (P
- Published
- 1997
11. Surgical treatment of acromegaly
- Author
-
MORTINI , PIETRO, Giugni E, Acerno S, Losa M. Giovanelli M., Von Werder K, Fahlbusch R, Mortini, Pietro, Giugni, E, Acerno, S, and Losa, M. Giovanelli M.
- Subjects
acromegaly ,pituitary - Published
- 1996
12. Responsiveness of gonadotropins to TRH in patients with nonfunctioning pituitary adenomas: correlation with immunoistochemical results
- Author
-
Losa M, Terreni MR, Acerno S, Giovanelli M., MORTINI , PIETRO, Losa, M, Terreni, Mr, Mortini, Pietro, Acerno, S, and Giovanelli, M.
- Published
- 1994
13. Indium-111 pentetreotide single-photon emission tomography in patients with TSH-secreting pituitary adenomas: correlation with the effect of a single administration of octreotide on serum TSH levels
- Author
-
Losa, M, Magnani, P, Mortini, P, Persani, L, Acerno, S, Giugni, E, Songini, C, Fazio, F, Beck Peccoz, P, Giovanelli, M, FAZIO, FERRUCCIO, Giovanelli, M., Losa, M, Magnani, P, Mortini, P, Persani, L, Acerno, S, Giugni, E, Songini, C, Fazio, F, Beck Peccoz, P, Giovanelli, M, FAZIO, FERRUCCIO, and Giovanelli, M.
- Abstract
Few data are available on the visualization of somatostatin receptors in vivo in patients with thyrotropin (TSH)-secreting adenoma. We studied five patients with TSH-secreting adenomas using single-photon emission tomography (SPET) after administration of indium-111 pentetreotide. The intensity of 111In-pentetreotide uptake by the tumours was correlated with the degree of TSH suppression after a single administration of 100 microg octreotide s. c. Five patients (three women and two men) aged 27-46 years were investigated. Except for one patient with acromegaly, all had pure TSH-secreting tumours. One patient was previously untreated, while two had received octreotide, one antithyroid drugs, and one radioiodine. In all patients SPET demonstrated increased uptake of 111In-pentetreotide by the pituitary adenoma. The target to non-target ratio (T/nT) of 111In-pentetreotide uptake was higher than 10 in three patients. Administration of 100 microg octreotide s. c. caused a significant reduction in TSH levels from 4.8+/-1.4 mU/l to a nadir of 3.1+/-1.1 mU/l after 6 h (P<0.001 by ANOVA). Suppression of TSH secretion ranged from 30% to 60% of the baseline value. The T/nT ratio showed a trend toward a direct relationship with the degree of TSH inhibition after acute octreotide administration (r=0.67; P=NS). Our study showed that 111In-pentetreotide scan visualized somatostatin receptors in all five of the patients with TSH-secreting pituitary adenomas, confirming the frequent presence of somatostatin receptors in these rare tumours, even though the correlation with the TSH inhibition after a single administration of octreotide did not reach significance.
- Published
- 1997
14. Surgical results in acromegaly: an analysis of over 300 patients
- Author
-
Martini, P., Losa, M., Lina Raffaella Barzaghi, Franzin, A., Mandelli, C., Acerno, S., and Giovanelli, M.
15. Radiosurgical treatment of arteriovenous malformations in a retrospective study group of 33 children: the importance of radiobiological scores
- Author
-
Carmen Rosaria Gigliotti, Francesco Scomazzoni, Antonella del Vecchio, Pietro Panni, Jody Filippo Capitanio, Stefania Acerno, Alberto Luigi Gallotti, Pietro Mortini, Capitanio, J. F., Panni, P., Gallotti, A. L., Gigliotti, C. R., Scomazzoni, F., Acerno, S., del Vecchio, A., and Mortini, P.
- Subjects
Intracranial Arteriovenous Malformations ,Male ,medicine.medical_specialty ,Adolescent ,medicine.medical_treatment ,Planning target volume ,Adult population ,Gamma knife ,Radiosurgery ,03 medical and health sciences ,0302 clinical medicine ,medicine ,Humans ,Pediatric radiosurgery ,Child ,Prospective cohort study ,Children ,Retrospective Studies ,business.industry ,Pediatric brain malformations ,Radiotherapy Planning, Computer-Assisted ,Retrospective cohort study ,General Medicine ,Child, Preschool ,030220 oncology & carcinogenesis ,Arteriovenous Fistula ,Pediatrics, Perinatology and Child Health ,Conventional PCI ,Female ,Neurology (clinical) ,Neurosurgery ,Radiology ,business ,030217 neurology & neurosurgery - Abstract
Purpose: Arteriovenous malformations’ (AVMs) obliteration depends on several factors; among the many factors that must be considered to obtain a high rate of obliteration and a low rate of complications, Flickinger-Pollock Score (FPS) seems to have an important role but still have to be validated in the pediatric population while Paddick-Conformity Index (PCI) still has no demonstration of its utility on the outcome and is considered only as a treatment quality marker. Methods: We retrospectively analyzed 33 consecutive children (2–18years) with an AVM, treated with stereotactic radiosurgery Gamma Knife (SRS-GK) from 2001 to 2014 in our institution. We assess angiographic (DSA) Obliteration Rate (OR) as well FPS and PCI to draw conclusions. Results: DSA-OR was 60.6% with a rate of hemorrhage of 0%. median target volume (TV) was 3.60cc (mean 4.32 ± 3.63; range 0.15–14.2), median PD was 22Gy (mean 21.4± 2.6; range 16.5–25). Median percentage of coverage was 98% (mean 97 ± 3; range 84–100). The median modified FPS was 0.78 (mean 0.89 ± 0.52; range 0.21–2.1) and highly correlate with OR (p = 0.01). The median PCI was 0.65 (mean 0.65 ± 0.14; range 0.34–0.95) A PCI lower than 0.57 highly correlates with final OR (p = 0.02). Conclusion: SRS-GK was safe and gradually effective in children. A prescription dose-like that used in adult population (i.e. > 18 and between 20 and 25Gy) is essential to achieve obliteration. A PD of 23Gy and 22Gy did impact OR, respectively (p= 0.02) and (p = 0.05). FPS and PCI are valuable scores that seem to correlate with the OR also in the pediatric population although further prospective studies are needed to confirm these observations.
- Published
- 2019
16. Cyst-cisternal shunting for cystic multirecurrent brainstem epidermoid: case report and literature review
- Author
-
Pietro Mortini, Filippo Gagliardi, Alfio Spina, Stefania Acerno, Nicola Boari, Michele Bailo, Mortini, Pietro, Bailo, M, Spina, A, Acerno, S, Boari, N, and Gagliardi, F.
- Subjects
medicine.medical_specialty ,Epidermal Cyst ,Brain tumor ,Epidermoid ,Cranial Nerve ,Neurosurgical Procedure ,Shunt ,Neurosurgical Procedures ,03 medical and health sciences ,Postoperative Complications ,0302 clinical medicine ,otorhinolaryngologic diseases ,medicine ,Humans ,Cyst ,Child ,Brain Diseases ,business.industry ,Cranial nerves ,Cranial Nerves ,Brain Disease ,medicine.disease ,Neurovascular bundle ,Surgery ,Shunting ,medicine.anatomical_structure ,Cranial Fossa, Posterior ,Posterior cranial fossa ,030220 oncology & carcinogenesis ,Cerebrospinal fluid circulation ,Female ,Postoperative Complication ,Neurology (clinical) ,Neurosurgery ,business ,Brainstem ,030217 neurology & neurosurgery ,Human - Abstract
Surgical treatment of recurrent, posterior cranial fossa epidermoids in multioperated patients carries significant morbidity, mainly due to tumor adhesion to cranial nerves and vessels, and brainstem involvement. Radical resection is often not feasible; therefore surgery should aim to restore cerebrospinal fluid circulation, release engulfed neurovascular structures, and relieve brainstem compression. Intra-axial epidermoids are extremely rare. We present an innovative surgical technique of a cyst-cisternal shunting to treat cystic recurrent, unresectable brainstem epidermoids. The surgical technique is stepwise described and a case illustration is reported. The pertinent literature has been reviewed. Few cases of brain stem epidermoid tumors have been described to date. The surgical steps of this technique and related intraoperative images are provided. One case illustration regarding the resection of a large recurrent cystic intra-axial brainstem epidermoid is reported to demonstrate the application of the technique in a clinical setting. The patient was followed up for 14 years and did not experience any recurrence, showing a stable disease at the last follow-up control. A systematic review of the competent literature has been provided. Cyst-cisternal shunting in case of recurrent, brainstem epidermoid is a safe and long-term effective technique to relieve mass effect into the brainstem.
- Published
- 2016
- Full Text
- View/download PDF
17. Prosepective Study to Evaluate Rate and Frequency of Perturbations of Implanted Programmable Hakim Codman Valve After 1.5-Tesla Magnetic Resonance Imaging
- Author
-
Alice Venier, Stefania Acerno, Jody Filippo Capitanio, Lucio Aniello Mazzeo, Pietro Mortini, Lina Raffaella Barzaghi, Capitanio, Jf, Venier, A, Mazzeo, La, Barzaghi, Lr, Acerno, S, and Mortini, Pietro
- Subjects
Implantable valve ,medicine.medical_specialty ,Magnetic field exposure ,Shunt susceptibility ,Ventriculoperitoneal Shunt ,030218 nuclear medicine & medical imaging ,03 medical and health sciences ,0302 clinical medicine ,Background exposure ,medicine ,Humans ,In patient ,Contraindication ,Hydrocephalu ,medicine.diagnostic_test ,business.industry ,Contraindications ,Magnetic resonance imaging ,Equipment Design ,Magnetic Resonance Imaging ,Key words Hakim-Codman programmable valve ,Surgery ,Equipment Failure Analysis ,Equipment Failure Analysi ,Equipment failure ,Italy ,Therapy, Computer-Assisted ,Equipment Failure ,Neurology (clinical) ,business ,Nuclear medicine ,030217 neurology & neurosurgery ,Shunt (electrical) ,Human - Abstract
Background Exposure to magnetic fields may alter the settings of programmable ventriculoperitoneal shunt valves or even cause permanent damages to these devices. There is little information about this topic, none on live patients. Objective To investigate the effects of 1.5-tesla magnetic resonance imaging (MRI) on Hakim-Codman (HC) pressure programmable valves implanted in our hospital. Methods A single-center prospective study to assess the rate of perturbations of HC programmable valve implanted. One hundred consecutive patients implanted for different clinical reasons between 2008 and 2012 were examined. A conventional skull x-ray before and after a standard MRI on 1.5 tesla. We evaluated before and after results, analyzed modification rate, and verified eventual damages to the implanted devices. Results Implanted HC valves are extremely handy and durable, even if they are likely to change often due to the exposure to magnetic fields. None of the patients complained of heating effects. Oscillations range from 10–30 mm H 2 O with a patient who reached 50 mm H 2 O and 1 who reached 60 mm H 2 O. Global alteration rate was 40%: 10 patients (10%) experienced a 10 mm H 2 O change; 14 patients (14%) had a 20 mm H 2 O change; 6 patients (6%) had a 30 mm H 2 O change; 8 patients (8%) had a 40 mm H 2 O change; 1 patient had a 50 mm H 2 O change; and 1 patient had a 60 mm H 2 O change. Conclusions HC valves presented a variable perturbation rate, with an alteration rate of 40% with 1.5-telsa MRI. We have not observed malfunctioning hardware as a result of magnetic influence. We claim a cranial x-ray immediately after the MRI because of a high risk (40%) of decalibration, especially in patients with low ventricles compliance.
- Published
- 2016
- Full Text
- View/download PDF
18. Correlation between clinical characteristics and proliferative activity in patients with craniopharyngioma
- Author
-
Stefania Acerno, Marco Losa, Pietro Mortini, Massimo Giovanelli, Alberto Vimercati, M. R. Terreni, G Santambrogio, F. Mangili, R. Barzaghi, Losa, M, Vimercati, A, Acerno, S, Barzaghi, Rl, Mortini, Pietro, Mangili, F, Terreni, Mr, Santambrogio, G, and Giovanelli, M.
- Subjects
Adult ,Male ,Paper ,Pathology ,medicine.medical_specialty ,Adolescent ,Proliferation index ,Cyclin A ,Craniopharyngioma ,Risk Factors ,Interquartile range ,Biomarkers, Tumor ,medicine ,Humans ,Child ,Aged ,biology ,Brain Neoplasms ,Cell Cycle ,Antibodies, Monoclonal ,Middle Aged ,Cell cycle ,medicine.disease ,Immunohistochemistry ,Magnetic Resonance Imaging ,Psychiatry and Mental health ,Ki-67 Antigen ,Diabetes insipidus ,Monoclonal ,biology.protein ,Female ,Surgery ,Neurology (clinical) ,Neoplasm Recurrence, Local - Abstract
OBJECTIVES: The aim of the study was to correlate the Ki-67 and cyclin A labelling index (LI) with clinical characteristics and risk of recurrence of craniopharyngiomas. METHODS: 47 consecutive patients were studied, 21 female and 26 male, aged 34.3 (2.8) years. Immunohistochemical analysis was performed on paraffin wax embedded material using monoclonal antibodies directed against the proliferation associated nuclear antigen Ki-67 and cyclin A. RESULTS: The median Ki-67 LI was 8.6% (interquartile range, 4.4%-14.0%). Ki-67 LI was significantly higher in tumours with a heavy inflammatory reaction and diabetes insipidus at presentation, whereas other clinical and histological features were not associated with the proliferation index. There was a strong linear correlation between Ki-67 LI and cyclin A LI (r = 0.77; p
- Published
- 2004
- Full Text
- View/download PDF
19. Indium-111 pentetreotide single-photon emission tomography in patients with TSH-secreting pituitary adenomas: correlation with the effect of a single administration of octreotide on serum TSH levels
- Author
-
Patrizia Magnani, F. Fazio, E. Giugni, C. Songini, Pietro Mortini, Luca Persani, Paolo Beck-Peccoz, Massimo Giovanelli, Stefania Acerno, Marco Losa, Losa, M, Magnani, P, Mortini, P, Persani, L, Acerno, S, Giugni, E, Songini, C, Fazio, F, Beck Peccoz, P, and Giovanelli, M
- Subjects
Adult ,Adenoma ,Male ,endocrine system ,medicine.medical_specialty ,Pituitary gland ,endocrine system diseases ,Octreotide ,Thyrotropin ,Pituitary neoplasm ,Pituitary adenoma ,Indium Radioisotope ,Internal medicine ,Acromegaly ,medicine ,Humans ,Radiology, Nuclear Medicine and imaging ,Pituitary Neoplasms ,Pituitary Neoplasm ,Receptors, Somatostatin ,Tomography, Emission-Computed, Single-Photon ,Somatostatin receptor ,business.industry ,Indium Radioisotopes ,General Medicine ,Middle Aged ,medicine.disease ,Hormone ,Hormones ,Endocrinology ,Somatostatin ,medicine.anatomical_structure ,Female ,business ,hormones, hormone substitutes, and hormone antagonists ,medicine.drug ,Human - Abstract
Few data are available on the visualization of somatostatin receptors in vivo in patients with thyrotropin (TSH)-secreting adenoma. We studied five patients with TSH-secreting adenomas using single-photon emission tomography (SPET) after administration of indium-111 pentetreotide. The intensity of 111In-pentetreotide uptake by the tumours was correlated with the degree of TSH suppression after a single administration of 100 microg octreotide s. c. Five patients (three women and two men) aged 27-46 years were investigated. Except for one patient with acromegaly, all had pure TSH-secreting tumours. One patient was previously untreated, while two had received octreotide, one antithyroid drugs, and one radioiodine. In all patients SPET demonstrated increased uptake of 111In-pentetreotide by the pituitary adenoma. The target to non-target ratio (T/nT) of 111In-pentetreotide uptake was higher than 10 in three patients. Administration of 100 microg octreotide s. c. caused a significant reduction in TSH levels from 4.8+/-1.4 mU/l to a nadir of 3.1+/-1.1 mU/l after 6 h (P
- Published
- 1997
20. Metastatic prostatic adenocarcinoma presenting as a pituitary mass: Shrinkage of the lesion and clinical improvement with medical treatment
- Author
-
Pietro Mortini, Massimo Giovanelli, Stefania Acerno, Enrico Giugni, Marco Grasso, Marco Losa, Losa, M, Grasso, M, Giugni, E, Mortini, Pietro, Acerno, S, and Giovanelli, M.
- Subjects
Male ,medicine.medical_specialty ,Time Factors ,medicine.drug_class ,Urology ,Biopsy ,Bone Neoplasms ,Pituitary neoplasm ,Adenocarcinoma ,Antiandrogen ,Flutamide ,Lesion ,Diagnosis, Differential ,Prostate cancer ,chemistry.chemical_compound ,Prostate ,Antineoplastic Combined Chemotherapy Protocols ,medicine ,Humans ,Pituitary Neoplasms ,Neoplasm Metastasis ,Metastatic Prostatic Adenocarcinoma ,Aged ,medicine.diagnostic_test ,business.industry ,Prostatic Neoplasms ,medicine.disease ,Magnetic Resonance Imaging ,Surgery ,medicine.anatomical_structure ,Oncology ,chemistry ,medicine.symptom ,Leuprolide ,business - Abstract
BACKGROUND. Metastatic involvement of the pituitary gland is a very unusual presentation of prostatic cancer. We report a favorable response to medical treatment in such a patient. METHODS AND RESULTS. A 77-year-old man presented with blindness, ophthalmoplegia in his left eye, and mild impairment of memory and mental status. Neuroradiological studies showed a huge intra- and suprasellar lesion that destroyed the sellar floor and extended into the sphenoid sinus. Transsphenoidal biopsy of the lesion demonstrated a prostatic adenocarcinoma. Postoperative studies revealed an enlarged prostate gland and multiple lytic bone lesions. The patient was treated with a combination of leuprolide acetate plus flutamide. Four months later, the patient exhibited a marked improvement in his neurologic status and regained vision in the right eye (visual acuity 6/20). Repeat magnetic resonance imaging of the sellar region confirmed a striking shrinkage of the prostatic metastasis. The clinical status remained stable for 22 months, after which time the disease progressed and the patient died 25 months after beginning treatment. CONCLUSIONS. A favorable response to combined androgen blockade suggests that medical therapy should be considered the therapy of first choice when surgical removal of the metastatic lesion in the pituitary is impossible or too risky. Prostate 32:241-245, 1997.
- Published
- 1997
21. Efficacy of radiotherapy and stereotactic radiosurgery as adjuvant or salvage treatment in atypical and anaplastic (WHO grade II and III) meningiomas: a systematic review and meta-analysis.
- Author
-
Gagliardi F, De Domenico P, Snider S, Pompeo E, Roncelli F, Barzaghi LR, Acerno S, and Mortini P
- Subjects
- Humans, Treatment Outcome, Salvage Therapy, Retrospective Studies, World Health Organization, Neoplasm Recurrence, Local radiotherapy, Neoplasm Recurrence, Local surgery, Neoplasm Recurrence, Local pathology, Follow-Up Studies, Meningioma radiotherapy, Meningioma surgery, Meningioma pathology, Radiosurgery, Meningeal Neoplasms radiotherapy, Meningeal Neoplasms surgery, Meningeal Neoplasms pathology
- Abstract
The role of radiotherapy (RT) and stereotactic radiosurgery (SRS) as adjuvant or salvage treatment in high-grade meningiomas (HGM) is still debated. Despite advances in modern neuro-oncology, HGM (WHO grade II and III) remains refractory to multimodal therapies. Published reports present aggregated data and are extremely varied in population size, exclusion criteria, selection bias, and inclusion of mixed histologic grades, making it extremely difficult to draw conclusions when taken individually. This current work aims to gather the existing evidence on RT and SRS as adjuvants following surgery or salvage treatment at recurrence after multimodality therapy failure and to conduct a systematic comparison between these two modalities. An extensive systematic literature review and meta-analysis were performed. A total of 42 papers were eligible for final analysis (RT n = 27; SRS n = 15) after searching MEDLINE via PubMed, Web-of-science, Cochrane Wiley, and Embase databases. Adjuvant regimens were addressed in 37 papers (RT n = 26; SRS n = 11); salvage regimens were described in 5 articles (RT n = 1; SRS n = 4). The primary outcomes of the study were the overall recurrence rate and mortality. Other actuarial rates (local and distant control, OS, PFS, and complications) were retrieved and analyzed as secondary outcomes. A total of 2853 patients harboring 3077 HGM were included. The majority were grade II (87%) with a mean pre-radiation volume of 8.7 cc. Adjuvant regimen: 2742 patients (76.4% RT; 23.6% SRS) with an overall grade II/III rate of 6.6/1. Lesions treated adjSRS were more frequently grade III (17 vs 12%, p < 0.001), and received subtotal resection (57 vs 27%, p = 0.001) compared to the RT cohort. AdjSRS cohort had a significantly shorter mean follow-up than adjRT (36.7 vs 50.3 months, p = 0.01). The overall recurrence rate was 38% in adjRT vs 25% in adjSRS (p = 0.01), while mortality did not differ between the groups (20% vs 23%, respectively; p = 0.80). The median time to recurrence was 1.5 times longer in the RT group (p = 0.30). Five-year local control was 55% in adjRT and 26% in adjSRS (p = 0.01), while 5-year OS was 73% and 78% (p = 0.62), and 5-year PFS was 62% and 40% in adjRT and adjSRS (p = 0.008). No difference in the incidence of complications (24% vs 14%, p = 0.53). Salvage regimen: 110 patients (37.3% RT; 62.7% SRS) with a grade II/III rate of 8.6/1. The recurrence rate was 46% in salRT vs 24% in salSRS (p = 0.39), time to recurrence was 1.8 times longer in the salRT group (35 vs 18.5 months, p = 0.74). Mortality was slightly yet not significantly higher in salRT (34% vs 12%, p = 0.54). Data on local and distant control were only available for salSRS. The 5-year OS was 49% and 83% (p = 0.90), and the 5-year PFS was 39% and 50% in salRT and salSRS (p = 0.66), respectively. High-grade meningiomas (WHO grade II and III) receiving adjuvant RT showed a higher overall recurrence rate than meningiomas receiving adjuvant SRS. The adjRT cohort, however, achieved higher 5-year LC and PFS rates, thus suggesting a potentially longer time to recurrence compared to adjSRS patients, who, meanwhile, experienced a significantly shorter follow-up. This result must also consider the higher number of grade III lesions and the smaller extent of resection achieved in the adjSRS group. Overall mortality did not differ between the two groups. No differences in outcome measures were observed in salvage regimens., (© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.)
- Published
- 2023
- Full Text
- View/download PDF
22. History of Evolution of Posterolateral Approaches to the Thoracic Spine: From Cure of Pott's Disease to Epidural Tumor Resection.
- Author
-
Gagliardi F, Pompeo E, De Domenico P, Snider S, Roncelli F, Acerno S, and Mortini P
- Subjects
- Humans, Spine, Paraplegia etiology, Tuberculosis, Spinal complications, Tuberculosis, Spinal surgery, Epidural Neoplasms complications, Spinal Cord Compression surgery
- Abstract
Since the end of the nineteenth century, the wide dissemination of Pott's disease has ignited debates about which should be the ideal route to perform ventrolateral decompression of the dorsal spine in case of paraplegia due to spinal cord compression in tuberculosis spondylitis. It was immediately clear that the optimal approach should be the one minimizing the surgical manipulation on both neural and extraneural structures while optimizing the exposure and surgical maneuverability on the target area. The first attempt was reported by Victor Auguste Menard in 1894, who described, for the first time, a completely different route from traditional laminectomy, called costotransversectomy. The technique was conceived to drain tubercular paravertebral abscesses causing paraplegia without manipulating the spinal cord. Over the following decades, many other routes have been described all over the world, thus demonstrating the wide interest on the topic. Surgical development has been marked by the new technical achievements and by instrumental/technological advancements, until the advent of portal surgery and endoscopy-assisted techniques. In this article, the authors retraced the milestones of this history up to the present days, through a systematic review on the topic., Competing Interests: None declared., (Thieme. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
23. Comparison between inferior frontal gyrus intrinsic connectivity network and verb-generation task fMRI network for presurgical language mapping in healthy controls and in glioma patients.
- Author
-
Cirillo S, Battistella G, Castellano A, Sanvito F, Iadanza A, Bailo M, Barzaghi RL, Acerno S, Mortini P, Gorno-Tempini ML, Mandelli ML, and Falini A
- Subjects
- Humans, Language, Brain Mapping, Prefrontal Cortex, Magnetic Resonance Imaging, Glioma diagnostic imaging, Glioma surgery
- Abstract
Task-based functional MRI (tb-fMRI) represents an extremely valuable approach for the identification of language eloquent regions for presurgical mapping in patients with brain tumors. However, its routinely application is limited by patient-related factors, such as cognitive disability and difficulty in coping with long-time acquisitions, and by technical factors, such as lack of equipment availability for stimuli delivery. Resting-state fMRI (rs-fMRI) instead, allows the identification of distinct language networks in a 10-min acquisition without the need of performing active tasks and using specific equipment. Therefore, to test the feasibility of rs-fMRI as a preoperative mapping tool, we reconstructed a lexico-semantic intrinsic connectivity network (ICN) in healthy controls (HC) and in a case series of patients with gliomas and compared the organization of this language network with the one derived from tb-fMRI in the patient's group. We studied three patients with extra-frontal gliomas who underwent functional mapping with auditory verb-generation (AVG) task and rs-fMRI with a seed in the left inferior frontal gyrus (IFG). First, we identified the functional connected areas to the IFG in HC. We qualitatively compared these areas with those that showed functional activation in AVG task derived from Neurosynth meta-analysis. Last, in each patient we performed single-subject analyses both for rs- and tb-fMRI, and we evaluated the spatial overlap between the two approaches. In HC, the IFG-ICN network showed a predominant left fronto-temporal functional connectivity in regions overlapping with the AVG network derived from a meta-analysis. In two patients, rs- and tb-fMRI showed comparable patterns of activation in left fronto-temporal regions, with different levels of contralateral activations. The third patient could not accomplish the AVG task and thus it was not possible to make any comparison with the ICN. However, in this patient, task-free approach disclosed a consistent network of fronto-temporal regions as in HC, and additional parietal regions. Our preliminary findings support the value of rs-fMRI approach for presurgical mapping, particularly for identifying left fronto-temporal core language-related areas in glioma patients. In a preoperative setting, rs-fMRI approach could represent a powerful tool for the identification of eloquent language areas, especially in patients with language or cognitive impairments., (© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.)
- Published
- 2022
- Full Text
- View/download PDF
24. Pediatric cerebellar pilocytic astrocytoma presenting with spontaneous intratumoral hemorrhage.
- Author
-
Donofrio CA, Gagliardi F, Callea M, da Passano CF, Terreni MR, Cavalli A, Spina A, Acerno S, Bailo M, Elbabaa SK, and Mortini P
- Subjects
- Astrocytoma surgery, Cerebellar Neoplasms surgery, Cerebral Hemorrhage therapy, Child, Humans, Male, Astrocytoma complications, Astrocytoma diagnosis, Cerebellar Neoplasms complications, Cerebellar Neoplasms diagnosis, Cerebral Hemorrhage diagnosis, Cerebral Hemorrhage etiology
- Abstract
Pilocytic astrocytomas (PAs) are benign glial tumors and one of the most common childhood posterior fossa tumors. Spontaneous intratumoral hemorrhage in PAs occurs occasionally, in about 8-20% of cases. Cerebellar hemorrhages in pediatric population are rare and mainly due to head injuries, rupture of vascular malformations, infections, or hematological diseases. We have investigated the still controversial and unclear pathophysiology underlying intratumoral hemorrhage in PAs. Bleeding in low-grade tumors might be related to structural abnormalities and specific angio-architecture of tumor vessels, such as degenerative mural hyalinization, "glomeruloid" endothelial proliferation, presence of encased micro-aneurysms, and glioma-induced neoangiogenesis. The acute hemorrhagic presentation of cerebellar PA in childhood although extremely uncommon is of critical clinical importance and necessitates promptly treatment. We described a case of hemorrhagic cerebellar PA in a 9-year-old child and reviewed the English-language literature that reported spontaneous hemorrhagic histologically proven cerebellar PA in pediatric patients (0-18 years). According to our analysis, the mortality was not related to symptom onset, tumor location, hemorrhage distribution, presence of acute hydrocephalous, and timing of surgery, while the GCS at hospital admission resulted to be the only statistically significant prognostic factor affecting survival outcome. The abrupt onset of signs and symptoms of acute hydrocephalous and consequent raised intracranial pressure are life-threatening conditions, which need emergent medical and neurosurgical treatments. At a later time, the identification of posterior fossa hemorrhage etiology is crucial to select the appropriate treatment and address the surgical strategy, optimizing the postoperative results.
- Published
- 2020
- Full Text
- View/download PDF
25. Sublabial transsphenoidal microsurgical technique to treat congenital transsphenoidal encephalocele: a technical note.
- Author
-
Albano L, Parisi V, Acerno S, Barzaghi LR, Losa M, and Mortini P
- Subjects
- Child, Preschool, Humans, Labial Frenum, Magnetic Resonance Imaging, Male, Sphenoid Bone surgery, Tomography, X-Ray Computed, Treatment Outcome, Encephalocele congenital, Encephalocele surgery, Microsurgery methods
- Abstract
Encephalocele is a rare malformation consisting in herniation of cranial contents through a cranial defect. A transsphenoidal location is uncommon, representing 5% of all basal encephaloceles. The surgical treatment of transsphenoidal encephaloceles is challenging. An optimal approach has not yet been determined, and it varies according to the surgical experience. We report the surgical management of a transsphenoidal encephalocele. The encephalocele and the sellar defect were repaired through a sublabial transsphenoidal microsurgical approach (TSM). Preoperative magnetic resonance imaging (MRI) and computed tomography (CT) scans were crucial for surgical planning. The sublabial transsphenoidal microsurgical approach offered a good and complete exposure of both the sac and the bone defect. Therefore, the congenital defect was successfully repaired with complete resolution of the encephalocele without any surgical or medical complications. Postoperative CT scan and MRI showed the restoration of the bone defect and the recovery of a normal anatomy with herniated structures pushed back into the sella. The described sublabial transsphenoidal microsurgical approach represents a minimally invasive, safe, and effective treatment strategy for transsphenoidal encephalocele.
- Published
- 2019
- Full Text
- View/download PDF
26. Radiosurgical treatment of arteriovenous malformations in a retrospective study group of 33 children: the importance of radiobiological scores.
- Author
-
Capitanio JF, Panni P, Gallotti AL, Gigliotti CR, Scomazzoni F, Acerno S, Del Vecchio A, and Mortini P
- Subjects
- Adolescent, Arteriovenous Fistula pathology, Child, Child, Preschool, Female, Humans, Intracranial Arteriovenous Malformations pathology, Male, Retrospective Studies, Arteriovenous Fistula radiotherapy, Intracranial Arteriovenous Malformations radiotherapy, Radiosurgery methods, Radiotherapy Planning, Computer-Assisted methods
- Abstract
Purpose: Arteriovenous malformations' (AVMs) obliteration depends on several factors; among the many factors that must be considered to obtain a high rate of obliteration and a low rate of complications, Flickinger-Pollock Score (FPS) seems to have an important role but still have to be validated in the pediatric population while Paddick-Conformity Index (PCI) still has no demonstration of its utility on the outcome and is considered only as a treatment quality marker., Methods: We retrospectively analyzed 33 consecutive children (2-18 years) with an AVM, treated with stereotactic radiosurgery Gamma Knife (SRS-GK) from 2001 to 2014 in our institution. We assess angiographic (DSA) Obliteration Rate (OR) as well FPS and PCI to draw conclusions., Results: DSA-OR was 60.6% with a rate of hemorrhage of 0%. median target volume (TV) was 3.60 cc (mean 4.32 ± 3.63; range 0.15-14.2), median PD was 22 Gy (mean 21.4 ± 2.6; range 16.5-25). Median percentage of coverage was 98% (mean 97 ± 3; range 84-100). The median modified FPS was 0.78 (mean 0.89 ± 0.52; range 0.21-2.1) and highly correlate with OR (p = 0.01). The median PCI was 0.65 (mean 0.65 ± 0.14; range 0.34-0.95) A PCI lower than 0.57 highly correlates with final OR (p = 0.02)., Conclusion: SRS-GK was safe and gradually effective in children. A prescription dose-like that used in adult population (i.e. > 18 and between 20 and 25 Gy) is essential to achieve obliteration. A PD of 23 Gy and 22 Gy did impact OR, respectively (p = 0.02) and (p = 0.05). FPS and PCI are valuable scores that seem to correlate with the OR also in the pediatric population although further prospective studies are needed to confirm these observations.
- Published
- 2019
- Full Text
- View/download PDF
27. Usefulness of Ultrasound-Guided Microsurgery in Cavernous Angioma Removal.
- Author
-
Barzaghi LR, Capitanio JF, Giudice L, Panni P, Acerno S, and Mortini P
- Subjects
- Adolescent, Adult, Aged, Brain Neoplasms surgery, Female, Follow-Up Studies, Hemangioma, Cavernous surgery, Humans, Intraoperative Neurophysiological Monitoring statistics & numerical data, Male, Microsurgery statistics & numerical data, Middle Aged, Operative Time, Retrospective Studies, Ultrasonography, Interventional statistics & numerical data, Young Adult, Brain Neoplasms diagnostic imaging, Hemangioma, Cavernous diagnostic imaging, Intraoperative Neurophysiological Monitoring methods, Microsurgery methods, Ultrasonography, Interventional methods
- Abstract
Background: Primary elements of surgical treatment of cavernous angiomas (CAs) are precise lesion identification and optimal trajectory determination. Navigation techniques allow for better results compared to microsurgery alone. In this study, we examined the benefits of intraoperative ultrasound (IOUS) use as an adjunct to standard localization systems., Methods: We retrospectively analyzed 59 CAs, comparing outcomes in 2 groups of patients: 34 who underwent frame-based or frameless navigation-assisted microsurgery (no-IOUS group) and 25 who underwent IOUS-guided microsurgery associated with these techniques (IOUS group)., Results: The use of IOUS did not significantly increase the surgery time (mean, 172 ± 1.7 minutes in the IOUS group and 192.6 ± 11.5 in no-IOUS group; P = 0.08). In all 25 patients in the IOUS group, IOUS allowed for ready identification of CA as a hyperechoic mass. At the last follow-up (mean, 41.7 ± 3.5 months postsurgery), 95.2% of the IOUS group and 80.8% of the no-IOUS group had a modified Rankin Scale score of 0-1 and an Extended Glasgow Outcome Scale score of 7-8 (P = 0.2), with 100% and 64%, respectively, included in Engel outcome scale class IA (P = 0.006). Complete removal, as confirmed on postoperative magnetic resonance imaging, was achieved in all patients in the IOUS group and in almost all (97.1%; P = 0.4) patients in the no-IOUS group., Conclusions: IOUS is a valid tool for the intraoperative identification of CAs. Implementation of standard localization methods with IOUS guidance was associated with complete resection in all cases, without increasing surgical time. Compared with microsurgery without IOUS guidance, long-term functional outcomes showed better trends, and the epilepsy-free rate was significantly higher., (Copyright © 2018 Elsevier Inc. All rights reserved.)
- Published
- 2018
- Full Text
- View/download PDF
28. Intrathecal rituximab for IgG 4 -related hypertrophic pachymeningitis.
- Author
-
Della-Torre E, Campochiaro C, Cassione EB, Albano L, Gerevini S, Bianchi-Marzoli S, Bozzolo E, Passerini G, Lanzillotta M, Terreni M, Callea M, Trimarchi M, Mortini P, Tresoldi M, Acerno S, and Dagna L
- Subjects
- Atrophy, Humans, Immunoglobulin G4-Related Disease diagnostic imaging, Infusions, Spinal, Magnetic Resonance Imaging, Meninges diagnostic imaging, Meningitis diagnostic imaging, Optic Nerve diagnostic imaging, Optic Nerve pathology, Optic Neuritis diagnostic imaging, Tomography, Optical Coherence, Visual Field Tests, White Matter diagnostic imaging, Young Adult, Immunoglobulin G4-Related Disease drug therapy, Immunologic Factors therapeutic use, Meningitis drug therapy, Optic Neuritis drug therapy, Rituximab therapeutic use
- Abstract
Competing Interests: Competing interests: None declared.
- Published
- 2018
- Full Text
- View/download PDF
29. Cyst-cisternal shunting for cystic multirecurrent brainstem epidermoid: case report and literature review.
- Author
-
Mortini P, Bailo M, Spina A, Acerno S, Boari N, and Gagliardi F
- Subjects
- Child, Cranial Nerves pathology, Female, Humans, Neurosurgical Procedures adverse effects, Postoperative Complications prevention & control, Brain Diseases surgery, Cranial Fossa, Posterior surgery, Epidermal Cyst surgery, Neurosurgical Procedures methods
- Abstract
Background: Surgical treatment of recurrent, posterior cranial fossa epidermoids in multioperated patients carries significant morbidity, mainly due to tumor adhesion to cranial nerves and vessels, and brainstem involvement. Radical resection is often not feasible; therefore surgery should aim to restore cerebrospinal fluid circulation, release engulfed neurovascular structures, and relieve brainstem compression. Intra-axial epidermoids are extremely rare. We present an innovative surgical technique of a cyst-cisternal shunting to treat cystic recurrent, unresectable brainstem epidermoids., Methods: The surgical technique is stepwise described and a case illustration is reported. The pertinent literature has been reviewed., Results: Few cases of brain stem epidermoid tumors have been described to date. The surgical steps of this technique and related intraoperative images are provided. One case illustration regarding the resection of a large recurrent cystic intra-axial brainstem epidermoid is reported to demonstrate the application of the technique in a clinical setting. The patient was followed up for 14 years and did not experience any recurrence, showing a stable disease at the last follow-up control. A systematic review of the competent literature has been provided., Conclusions: Cyst-cisternal shunting in case of recurrent, brainstem epidermoid is a safe and long-term effective technique to relieve mass effect into the brainstem.
- Published
- 2016
- Full Text
- View/download PDF
30. Prosepective Study to Evaluate Rate and Frequency of Perturbations of Implanted Programmable Hakim Codman Valve After 1.5-Tesla Magnetic Resonance Imaging.
- Author
-
Capitanio JF, Venier A, Mazzeo LA, Barzaghi LR, Acerno S, and Mortini P
- Subjects
- Contraindications, Equipment Design, Equipment Failure Analysis statistics & numerical data, Humans, Italy epidemiology, Therapy, Computer-Assisted instrumentation, Equipment Failure statistics & numerical data, Magnetic Resonance Imaging instrumentation, Magnetic Resonance Imaging statistics & numerical data, Therapy, Computer-Assisted statistics & numerical data, Ventriculoperitoneal Shunt instrumentation, Ventriculoperitoneal Shunt statistics & numerical data
- Abstract
Background: Exposure to magnetic fields may alter the settings of programmable ventriculoperitoneal shunt valves or even cause permanent damages to these devices. There is little information about this topic, none on live patients., Objective: To investigate the effects of 1.5-tesla magnetic resonance imaging (MRI) on Hakim-Codman (HC) pressure programmable valves implanted in our hospital., Methods: A single-center prospective study to assess the rate of perturbations of HC programmable valve implanted. One hundred consecutive patients implanted for different clinical reasons between 2008 and 2012 were examined. A conventional skull x-ray before and after a standard MRI on 1.5 tesla. We evaluated before and after results, analyzed modification rate, and verified eventual damages to the implanted devices., Results: Implanted HC valves are extremely handy and durable, even if they are likely to change often due to the exposure to magnetic fields. None of the patients complained of heating effects. Oscillations range from 10-30 mm H2O with a patient who reached 50 mm H2O and 1 who reached 60 mm H2O. Global alteration rate was 40%: 10 patients (10%) experienced a 10 mm H2O change; 14 patients (14%) had a 20 mm H2O change; 6 patients (6%) had a 30 mm H2O change; 8 patients (8%) had a 40 mm H2O change; 1 patient had a 50 mm H2O change; and 1 patient had a 60 mm H2O change., Conclusions: HC valves presented a variable perturbation rate, with an alteration rate of 40% with 1.5-telsa MRI. We have not observed malfunctioning hardware as a result of magnetic influence. We claim a cranial x-ray immediately after the MRI because of a high risk (40%) of decalibration, especially in patients with low ventricles compliance., (Copyright © 2016 Elsevier Inc. All rights reserved.)
- Published
- 2016
- Full Text
- View/download PDF
31. Neurosurgical treatment of craniopharyngioma in adults and children: early and long-term results in a large case series.
- Author
-
Mortini P, Losa M, Pozzobon G, Barzaghi R, Riva M, Acerno S, Angius D, Weber G, Chiumello G, and Giovanelli M
- Subjects
- Adolescent, Adult, Aged, Cause of Death, Child, Craniopharyngioma diagnosis, Craniopharyngioma mortality, Craniotomy, Endoscopy, Female, Follow-Up Studies, Humans, Magnetic Resonance Imaging, Male, Middle Aged, Neoplasm Recurrence, Local diagnosis, Neoplasm Recurrence, Local etiology, Neoplasm Recurrence, Local mortality, Neoplasm Recurrence, Local surgery, Neoplasm, Residual diagnosis, Neoplasm, Residual etiology, Neoplasm, Residual mortality, Neoplasm, Residual surgery, Pituitary Neoplasms diagnosis, Pituitary Neoplasms mortality, Postoperative Complications diagnosis, Postoperative Complications mortality, Postoperative Complications surgery, Quality of Life, Radiosurgery, Reoperation, Survival Rate, Tomography, X-Ray Computed, Craniopharyngioma surgery, Pituitary Neoplasms surgery, Postoperative Complications etiology
- Abstract
Object: Craniopharyngioma accounts for 2%-5% of all primary intracranial neoplasms. The optimal management of craniopharyngioma remains controversial. The authors evaluated the early results of surgery and the longterm risk of tumor recurrence in a large series of patients undergoing resection of craniopharyngiomas., Methods: Between 1990 and 2008, 112 consecutive patients (57 male and 55 female patients with a mean [± SEM] age of 33.3 ± 1.8 years) underwent resection of craniopharyngiomas at the authors' hospital. Recurrence or growth of residual tumor tissue during follow-up was assessed using MR imaging., Results: There were 3 perioperative deaths (2.7%). Severe adverse events were more frequent in patients who underwent operations via the transcranial route (37%) than the transsphenoidal approach (5.6%; p < 0.001). Magnetic resonance imaging showed radical resection of the tumor in 78 (71.6%) of the remaining 109 patients. Previous surgery and maximum tumor diameter were associated with persistence of disease after surgery. Craniopharyngioma recurred in 26 (24.5%) of 106 patients. Presence of residual tumor on the first postoperative MR imaging, male sex, and no postoperative radiation therapy were associated with a risk of tumor recurrence. Quality-of-life data were assessed in the 91 patients who attended the authors' institution for follow-up visits. Among them, 8.8% patients were partially or completely dependent on others for daily living activities before surgery. This percentage increased to 14.3% at the last follow-up visit. The 5- and 10-year overall survival rates were 94.4% (95% CI 90.0%-98.8%) and 90.3% (95% CI 83.4%-97.3%), respectively., Conclusions: Complete surgical removal of craniopharyngioma can be achieved with reasonable safety in more than 70% of patients. Recurrence of craniopharyngioma may occur even after apparent radical excision. Prompt management of residual or recurring disease by radiotherapy, repeat surgery, or a combination of both is usually successful in controlling further tumor growth.
- Published
- 2011
- Full Text
- View/download PDF
32. A case of melanotic desmoplastic ganglioglioma.
- Author
-
Antonelli M, Acerno S, Baldoli C, Terreni MR, and Giangaspero F
- Subjects
- Brain Neoplasms ultrastructure, Follow-Up Studies, Ganglioglioma ultrastructure, Humans, Infant, Magnetic Resonance Imaging, Male, Temporal Lobe metabolism, Temporal Lobe pathology, Temporal Lobe ultrastructure, Brain Neoplasms metabolism, Brain Neoplasms pathology, Ganglioglioma metabolism, Ganglioglioma pathology, Melanins metabolism
- Abstract
We describe a case of desmoplastic infantile ganglioglioma (DIG) in a 9-month-old boy located in the temporal lobe. Grossly the tumor was brown and superficially located. Histologically the tumor contained pigment in numerous neoplastic cells, shown to be melanosomal melanin by ultrastructural examination. Pigmented neoplasms have been reported at various sites in the central and peripheral nervous system. Previous reports on pigmented neuroepithelial tumors include neoplasms containing melanin, while others have contained neuromelanin and or lipofuscin. This case represents the first description of pigmented neoplastic cells in DIG, enlarging the spectrum of pigmented primary CNS tumors.
- Published
- 2009
- Full Text
- View/download PDF
33. No salvage using high-dose chemotherapy plus/minus reirradiation for relapsing previously irradiated medulloblastoma.
- Author
-
Massimino M, Gandola L, Spreafico F, Biassoni V, Luksch R, Collini P, Solero CN, Simonetti F, Pignoli E, Cefalo G, Poggi G, Modena P, Mariani L, Potepan P, Podda M, Casanova M, Pecori E, Acerno S, Ferrari A, Terenziani M, Meazza C, Polastri D, Ravagnani F, and Fossati-Bellani F
- Subjects
- Adolescent, Antineoplastic Combined Chemotherapy Protocols adverse effects, Carboplatin administration & dosage, Carboplatin adverse effects, Child, Child, Preschool, Cisplatin administration & dosage, Cisplatin adverse effects, Combined Modality Therapy methods, Cyclophosphamide administration & dosage, Cyclophosphamide adverse effects, Disease-Free Survival, Drug Administration Schedule, Etoposide administration & dosage, Etoposide adverse effects, Female, Granulocyte Colony-Stimulating Factor administration & dosage, Humans, Male, Methotrexate administration & dosage, Methotrexate adverse effects, Radiotherapy Dosage, Remission Induction methods, Thiotepa administration & dosage, Thiotepa adverse effects, Vincristine administration & dosage, Vincristine adverse effects, Young Adult, Antineoplastic Combined Chemotherapy Protocols therapeutic use, Cerebellar Neoplasms drug therapy, Cerebellar Neoplasms mortality, Cerebellar Neoplasms radiotherapy, Cerebellar Neoplasms surgery, Medulloblastoma drug therapy, Medulloblastoma mortality, Medulloblastoma radiotherapy, Medulloblastoma surgery, Neoplasm Recurrence, Local drug therapy, Neoplasm Recurrence, Local mortality, Neoplasm Recurrence, Local radiotherapy, Neoplasm Recurrence, Local surgery, Salvage Therapy
- Abstract
Purpose: Myeloablative regimens were frequently used for medulloblastoma relapsing after craniospinal irradiation (CSI): in 1997-2002, we used repeated surgery, standard-dose and myeloablative chemotherapy, and reirradiation., Methods and Materials: In 10 patients, reinduction included sequential high-dose etoposide, high-dose cyclophosphamide/vincristine, and high-dose carboplatin/vincristine, then two myeloablative courses with high-dose thiotepa (+/- carboplatin); 6 other patients received two of four courses of cisplatin/etoposide. Hematopoietic precursor mobilization followed high-dose etoposide or high-dose cyclophosphamide or cisplatin/etoposide therapy. After the overall chemotherapy program, reirradiation was prescribed when possible., Results: Seventeen patients were treated: previous treatment included CSI of 19.5-36 Gy with posterior fossa/tumor boost and chemotherapy in 16 patients. Fifteen patients were in their first and 2 in their second and third relapses, respectively. First progression-free survival had lasted a median of 26 months. Relapse sites included leptomeninges in 9 patients, spine in 4 patients, posterior fossa in 3 patients, and brain in 1 patient. Three patients underwent complete resection of recurrence, and 10 underwent reirradiation. Twelve of 14 patients with assessable tumor had an objective response after reinduction; 2 experienced progression and were not given the myeloablative courses. Remission lasted a median of 16 months. Additional relapses appeared in 13 patients continuing the treatment. Fifteen patients died of progression and 1 died of pneumonia 13 months after relapse. The only survivor at 93 months had a single spinal metastasis that was excised and irradiated. Survival for the series as a whole was 11-93 months, with a median of 41 months., Conclusions: Despite responses being obtained and ample use of surgery and reirradiation, second-line therapy with myeloablative schedules was not curative, barring a few exceptions. A salvage therapy for medulloblastoma after CSI still needs to be sought.
- Published
- 2009
- Full Text
- View/download PDF
34. Metastatic prostatic adenocarcinoma presenting as a pituitary mass: shrinkage of the lesion and clinical improvement with medical treatment.
- Author
-
Losa M, Grasso M, Giugni E, Mortini P, Acerno S, and Giovanelli M
- Subjects
- Adenocarcinoma drug therapy, Adenocarcinoma pathology, Aged, Biopsy, Bone Neoplasms secondary, Diagnosis, Differential, Flutamide administration & dosage, Humans, Leuprolide administration & dosage, Magnetic Resonance Imaging, Male, Neoplasm Metastasis, Pituitary Neoplasms drug therapy, Pituitary Neoplasms pathology, Prostatic Neoplasms drug therapy, Prostatic Neoplasms surgery, Time Factors, Adenocarcinoma diagnosis, Adenocarcinoma secondary, Antineoplastic Combined Chemotherapy Protocols therapeutic use, Pituitary Neoplasms diagnosis, Pituitary Neoplasms secondary, Prostatic Neoplasms pathology
- Abstract
Background: Metastatic involvement of the pituitary gland is a very unusual presentation of prostatic cancer. We report a favorable response to medical treatment in such a patient., Methods and Results: A 77-year-old man presented with blindness, ophthalmoplegia in his left eye, and mild impairment of memory and mental status. Neuroradiological studies showed a huge intra- and suprasellar lesion that destroyed the sellar floor and extended into the sphenoid sinus. Transsphenoidal biopsy of the lesion demonstrated a prostatic adenocarcinoma. Postoperative studies revealed an enlarged prostate gland and multiple lytic bone lesions. The patient was treated with a combination of leuprolide acetate plus flutamide. Four months later, the patient exhibited a marked improvement in his neurologic status and regained vision in the right eye (visual acuity 6/20). Repeat magnetic resonance imaging of the sellar region confirmed a striking shrinkage of the prostatic metastasis. The clinical status remained stable for 22 months, after which time the disease progressed and the patient died 25 months after beginning treatment., Conclusions: A favorable response to combined androgen blockade suggests that medical therapy should be considered the therapy of first choice when surgical removal of the metastatic lesion in the pituitary is impossible or too risky.
- Published
- 1997
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.